Sheldon Brookman

Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing <i>Escherichia coli</i>

Eduardo López, María M Contrini, Eduardo Glatstein et al. · Antimicrobial Agents and Chemotherapy · 2009 · 101 citations · Full text

Microbial Toxin, Allergy, Health Sciences +13

An Epidemiologic Surveillance of Shiga-like Toxin-producing Escherichia coli Infection in Argentinean Children

Eduardo López, María M Contrini, Eduardo Glatstein et al. · The Pediatric Infectious Disease Journal · 2011 · 50 citations

Safety, Tolerability, and Exposure of Ciclesonide Nasal Spray in Healthy and Asymptomatic Subjects With Seasonal Allergic Rhinitis

Ruediger Nave, Mark A. Wingertzahn, Sheldon Brookman et al. · The Journal of Clinical Pharmacology · 2006 · 34 citations

Asthma, Allergy, Allergy Medicine +13

Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis

Paul H. Ratner, Mark A. Wingertzahn, Julius H. van Bavel et al. · Annals of Allergy Asthma & Immunology · 2006 · 29 citations

Asthma, Allergy, Allergy Medicine +5

A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Recurrent, Refractory or Progressive Primary Brain Tumors—Final Report (Protocol BT-22)

Stanisław R. Burzyński, Tomasz J. Janicki, Gregory S. Burzynski et al. · Journal of Cancer Therapy · 2014 · 27 citations · Full text

Surgical Oncology, Pediatric Brain Tumors, Recurrent Dipg +18